Business Context and Reporting Period
Company: Sanara Medtech Inc. (SMTI)
Filing Type: Form 8-K (Current Report)
Date of Report: March 2, 2026
Reporting Period: Event-based disclosure regarding an investor presentation scheduled for March 3, 2026, at the TD Cowen 46th Annual Health Care Conference.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the furnishing of an investor presentation containing summary information on strategy and anticipated revenue for the 2026 fiscal year.
Material Changes
No material financial changes or operational updates are detailed within the text of this Form 8-K. The document references an attached Exhibit 99.1 (Investor Presentation) which contains the Company's priorities and anticipated 2026 revenue, but the specific figures are not included in the filing text provided.
Guidance, Outlook, and Risks
- Outlook: The Company intends to present anticipated revenue for the 2026 fiscal year and discuss strategic priorities.
- Management Commentary: Management states the presentation contains summary information intended to be considered in the context of other SEC filings and public announcements.
- Forward-Looking Statements: The Company explicitly undertakes no duty or obligation to publicly update or revise the information contained in the presentation.
- Legal Status: Information in Item 7.01 and Exhibit 99.1 is furnished, not "filed," and shall not be deemed incorporated by reference into other filings under the Securities Act or Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Investor Presentation) for specific 2026 revenue guidance and strategic details not present in the 8-K text.
- Verify the date and location of the TD Cowen 46th Annual Health Care Conference (March 3, 2026, Boston, MA).
- Confirm that the furnished presentation is not legally incorporated by reference into other Company filings.
- Monitor subsequent press releases or 10-Q/10-K filings for updated financial data, as the Company disclaims an obligation to update the presentation.